PALE
MCID: PST092
MIFTS: 29

Posttransplant Acute Limbic Encephalitis (PALE)

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Posttransplant Acute Limbic Encephalitis

MalaCards integrated aliases for Posttransplant Acute Limbic Encephalitis:

Name: Posttransplant Acute Limbic Encephalitis 58
Pale 58

Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Orphanet 58 ORPHA163921

Summaries for Posttransplant Acute Limbic Encephalitis

MalaCards based summary : Posttransplant Acute Limbic Encephalitis, also known as pale, is related to clear cell acanthoma and deficiency anemia. The drugs mometasone furoate and Lansoprazole have been mentioned in the context of this disorder. Affiliated tissues include skin, liver and breast.

Related Diseases for Posttransplant Acute Limbic Encephalitis

Diseases related to Posttransplant Acute Limbic Encephalitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 235)
# Related Disease Score Top Affiliating Genes
1 clear cell acanthoma 11.9
2 deficiency anemia 11.3
3 obesity, early-onset, with adrenal insufficiency and red hair 11.2
4 pernicious anemia 11.2
5 oculocutaneous albinism 11.2
6 biliary atresia 11.2
7 hepatitis b 11.2
8 syncope 11.2
9 iron-refractory iron deficiency anemia 11.2
10 anemia, sideroblastic, 1 11.2
11 cardiomyopathy, infantile histiocytoid 11.1
12 glucosephosphate dehydrogenase deficiency 11.1
13 thoracic outlet syndrome 11.1
14 tietz albinism-deafness syndrome 11.0
15 clouston syndrome 11.0
16 optic atrophy 1 11.0
17 pyruvate kinase deficiency of red cells 11.0
18 cyclic vomiting syndrome 11.0
19 alpha-thalassemia 11.0
20 capillary malformation-arteriovenous malformation 1 11.0
21 erythroderma, ichthyosiform, congenital reticular 11.0
22 majeed syndrome 11.0
23 beta-thalassemia 11.0
24 macular dystrophy with central cone involvement 11.0
25 paroxysmal nocturnal hemoglobinuria 11.0
26 thalassemia 11.0
27 lepromatous leprosy 11.0
28 congenital dyserythropoietic anemia 11.0
29 waardenburg's syndrome 11.0
30 hypochromic microcytic anemia with iron overload 11.0
31 methylmalonic acidemia with homocystinuria 11.0
32 alagille syndrome 1 10.9
33 hashimoto thyroiditis 10.9
34 klippel-trenaunay-weber syndrome 10.9
35 systemic lupus erythematosus 10.9
36 chromosome 5q deletion syndrome 10.9
37 motion sickness 10.9
38 noonan syndrome 1 10.9
39 optic atrophy 3, autosomal dominant 10.9
40 paget disease, extramammary 10.9
41 pheochromocytoma 10.9
42 sturge-weber syndrome 10.9
43 atransferrinemia 10.9
44 folate malabsorption, hereditary 10.9
45 glutamate formiminotransferase deficiency 10.9
46 ghosal hematodiaphyseal dysplasia 10.9
47 hemolytic uremic syndrome, atypical 1 10.9
48 thiamine-responsive megaloblastic anemia syndrome 10.9
49 myeloma, multiple 10.9
50 3-methylglutaconic aciduria, type iii 10.9

Graphical network of the top 20 diseases related to Posttransplant Acute Limbic Encephalitis:



Diseases related to Posttransplant Acute Limbic Encephalitis

Symptoms & Phenotypes for Posttransplant Acute Limbic Encephalitis

Drugs & Therapeutics for Posttransplant Acute Limbic Encephalitis

Drugs for Posttransplant Acute Limbic Encephalitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 213)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
2
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
3
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6, 103577-45-3 9578005
4
Lactulose Approved Phase 4 4618-18-2 11333
5
Sodium citrate Approved, Investigational Phase 4 68-04-2
6
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
7
Sorbitol Approved Phase 4 50-70-4 5780
8
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
9
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
10
Moxifloxacin Approved, Investigational Phase 4 151096-09-2, 354812-41-2 152946
11
Polyestradiol phosphate Approved Phase 4 28014-46-2
12
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
13
Pantoprazole Approved Phase 4 102625-70-7 4679
14
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
15
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
16
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
17
Calcium carbonate Approved, Investigational Phase 4 471-34-1
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
19
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
20
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
21
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
22 Opiate Alkaloids Phase 4
23 Liver Extracts Phase 4
24 Antidepressive Agents Phase 4
25 Pharmaceutical Solutions Phase 4
26 Gastrointestinal Agents Phase 4
27 Autonomic Agents Phase 4
28 Antiemetics Phase 4
29 Anti-Inflammatory Agents Phase 4
30 Anti-Bacterial Agents Phase 4
31 Citrate Phase 4
32 Vaccines Phase 4
33 Anti-Ulcer Agents Phase 4
34 Antacids Phase 4
35 Cathartics Phase 4
36 Reverse Transcriptase Inhibitors Phase 4
37 Anti-Retroviral Agents Phase 4
38 Laxatives Phase 4
39 Anti-HIV Agents Phase 4
40 Contraceptive Agents Phase 4
41 Estradiol 17 beta-cypionate Phase 4
42 Norgestimate, ethinyl estradiol drug combination Phase 4
43 Contraceptives, Oral, Combined Phase 4
44 Contraceptives, Oral Phase 4
45 Estradiol 3-benzoate Phase 4
46 Calcium, Dietary Phase 4
47 Ophthalmic Solutions Phase 4
48 BB 1101 Phase 4
49 triamcinolone acetonide Phase 4
50 glucocorticoids Phase 4

Interventional clinical trials:

(show top 50) (show all 94)
# Name Status NCT ID Phase Drugs
1 Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial Unknown status NCT00615875 Phase 4 naproxen;placebo
2 a Randomized, Double Blind, Placebo-controlled, Multicenter Clinical Trial of Efficacy and Safety of Shu Gan yi Yang Capsule in the Treatment of Depression Associated With Erectile Dysfunction (Stagnation of Liver qi and Kidney Deficiency) Unknown status NCT03290313 Phase 4 shu gan yi yang capsule;shu gan yi yang capsule simulation agent
3 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate. A Randomized Controlled Trial Unknown status NCT02278081 Phase 4 lansoprazole;placebo
4 A Phase IV Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral Digital Subtraction Angiography (DSA) Completed NCT00740207 Phase 4 VISIPAQUE 270;Isovue 250
5 Clinical Outcomes of Endoscopic Resection for Treating Extremely Well Differentiated Intestinal-type Adenocarcinoma (WHYX Lesion) Completed NCT01451034 Phase 4
6 Blood Glucose Response After Oral Intake of Lactulose (Laevolac®) in Mildly Constipated Patients With Diabetes Mellitus Type 2 Completed NCT03666546 Phase 4 Lactulose crystals 20 g;Lactulose crystals 30 g;Lactulose liquid 20 g;Lactulose liquid 30 g;Glucose;Still water
7 An Open-label Single-Center, 4-Period William's Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects Completed NCT02634073 Phase 4 Lamivudine;Sorbitol
8 Ivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan Completed NCT02241044 Phase 4
9 A Two Different Chemoprophylaxis Approaches After Phacoemulsification Surgery in One Thousand Patients in Iraq :a Clinical Trial Completed NCT03634852 Phase 4 Moxifloxacin hydrochloride 0.5% eye drops;Dexamethasone 0.1% eye drops;Intracameral Moxifloxacin 0.1%;Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml
10 An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
11 Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules With RotaTeq® and Rotarix® Completed NCT01266850 Phase 4
12 A Randomized Comparison of Ultrasound Guided Supraclavicular Block(UGSB) and General Anesthesia (GA) to IV Narcotics and General Anesthesia for Postoperative Pain Relief in Children With Supracondylar Fractures. Active, not recruiting NCT02056288 Phase 4 Fentanyl;Ropivacaine
13 RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients) Terminated NCT00782639 Phase 4 Iopamidol injection 76%;iodixanol
14 Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients:A Multicentre Randomized Double-Blind Trail of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Terminated NCT01402219 Phase 4 Iopamidol injection 76%;iodixanol
15 Irinotecan-Eluting Bead (DEBIRI) for Unresectable Liver Metastases From Colorectal Cancer After Systemic Chemotherapy Failure Unknown status NCT03175016 Phase 2, Phase 3 Irinotecan
16 Open Label, Phase III Safety, Efficacy, and Pharmacokinetic Study of NABI-IGIV 10% [Immune Globulin Intravenous (Human), 10%] in Subjects With Primary Immune Deficiency Disorders (PIDD) Completed NCT00538915 Phase 3
17 An Open Label, Randomised, Three Arm, Single Dose, Multicentre, Parallel Group Study in Healthy Subjects to Compare the Pharmacokinetics of Subcutaneous Mepolizumab When Delivered as a Liquid Drug Product in a Safety Syringe or an Auto Injector With a Reconstituted Lyophilised Drug Product From a Vial Completed NCT03014674 Phase 3
18 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of an Autoinjector for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 204959) Completed NCT03099096 Phase 3 Mepolizumab
19 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667) Completed NCT03021304 Phase 3 Mepolizumab
20 A 52-week, Phase III, Open-label, Multi-center Study to Evaluate Efficacy and Safety of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease Completed NCT02791763 Phase 3 1 to 4 mg tablets of GSK1278863;6 mg GSK1278863 tablet;Epoetin beta pegol
21 A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib Recruiting NCT03459534 Phase 3 Radotinib HCl
22 A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease Active, not recruiting NCT02697734 Phase 3 osilodrostat;osilodrostat Placebo
23 A Randomised, Double-blind, Parallel Group PhIII Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab as an Add on to Maintenance Treatment in Adults With Severe Bilateral Nasal Polyps - SYNAPSE (StudY in NAsal Polyps Patients to Assess the Safety and Efficacy of Mepolizumab) Active, not recruiting NCT03085797 Phase 3 Mepolizumab;Placebo;Mometasone furoate
24 A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections Completed NCT02045797 Phase 2 GSK2140944 Lyophile;GSK2140944 Capsules
25 A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose Study to Evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients With Severe Asthma Completed NCT00843193 Phase 2 INTRAVENOUS GSK679586;INTRAVENOUS PLACEBO;FLUTICASONE PROPIONATE
26 A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae Completed NCT02294682 Phase 2 GSK2140944
27 Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD) Completed NCT02702817 Phase 2 Naproxen;Placebo
28 Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer Completed NCT02015754 Phase 2 DEBIRI
29 The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis Completed NCT02448082 Phase 2
30 A Pilot Phase 1/2, Double Blind, Parallel Group, Controlled Study of the Safety, Tolerability and Preliminary Efficacy Evaluation of Intravitreally Administered Pfenex Ranibizumab Biosimilar Versus Lucentis for the Treatment of Neovascular AMD Completed NCT02121353 Phase 1, Phase 2 Lucentis;PF582
31 Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers Completed NCT00066066 Phase 2 Metronidazole;Amoxicillin;Doxycycline
32 A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B Completed NCT01838655 Phase 1, Phase 2 Nitisinone
33 High Dose Testosterone in Men With Advanced Prostate Cancer and Homologous Recombination Deficiency Recruiting NCT03522064 Phase 2 Testosterone Enanthate
34 COMbination of Bipolar Androgen Therapy and Nivolumab in Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting NCT03554317 Phase 2 Testosterone cypionate;Nivolumab
35 A Phase II Study to Determine Sequential Response to Bipolar Androgen Therapy (BAT) Followed by Enzalutamide or Abiraterone Post-BAT in Men With Prostate Cancer Progressing on Combined Androgen Ablative Therapies Recruiting NCT02090114 Phase 2 Testosterone cypionate;Testosterone Enanthate;Abiraterone acetate;Enzalutamide (Cohort A = CLOSED TO ACCRUAL)
36 A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602). Active, not recruiting NCT03177239 Phase 2 Nivolumab;Ipilimumab
37 Examining an Intervention to Reduce Underage DUI and Riding With Impaired Drivers Active, not recruiting NCT03506880 Phase 2
38 An Open-Label, Phase II, Study to Evaluate Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Receiving Treatment With Trastuzumab in Combination With Lapatinib or Chemotherapy (EGF117165) Active, not recruiting NCT02213042 Phase 2 Lapatinib
39 A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer Active, not recruiting NCT02286921 Phase 2 Testosterone cypionate;Enzalutamide;Testosterone Enanthate
40 Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis: A Randomized Control Trial Enrolling by invitation NCT04130451 Phase 1, Phase 2 PYODINE AND TALC SLURRY
41 Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients Terminated NCT01808261 Phase 2 GSK249320 100/mg;Placebo
42 A Single-centre, Open Single-arm Study Where the Safety, Tolerability and Efficacy of Subcutaneously Administered ILB Will be Evaluated in Patients With Amyotrophic Lateral Sclerosis Terminated NCT03613571 Phase 2 ILB
43 A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery Terminated NCT02221037 Phase 2 GSK2862277;Placebo
44 A Phase II Study of Irinotecan HCI in Patients With Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas Terminated NCT00360828 Phase 2 Irinotecan Hydrochloride (HCI) Treatment;Continued Irinotecan Hydrochloride (HCI) Treatment
45 A Two Part Phase IIa Study, to Evaluate the Safety and Tolerability, Pharmacokinetics, Proof of Mechanism and Potential for Efficacy of an Anti-IL-7 Receptor-α Monoclonal Antibody (GSK2618960) in the Treatment of Primary Sjögren's Syndrome Withdrawn NCT03239600 Phase 2 GSK2618960 2 mg/kg;Placebo;Methotrexate
46 A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects Completed NCT00460707 Phase 1 Casopitant 150 mg;Ketoconazole;Casopitant 150 mg matching placebo;Casopitant 50 mg;Casopitant 50 mg matching placebo
47 An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666) Completed NCT01934205 Phase 1 GSK2140944 (Single dose);GSK2140944 (Multiple dose)
48 A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use With Dynamic Proteomic Measurement Completed NCT01962454 Phase 1 Deuterated Water;Testosterone enanthate;Placebo to match testosterone enanthate
49 A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector Completed NCT01894360 Phase 1 Belimumab 200 mg/mL
50 Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated FGF Pathway Signaling Completed NCT01868022 Phase 1 GSK3052230;paclitaxel;carboplatin;docetaxel;pemetrexed;cisplatin

Search NIH Clinical Center for Posttransplant Acute Limbic Encephalitis

Genetic Tests for Posttransplant Acute Limbic Encephalitis

Anatomical Context for Posttransplant Acute Limbic Encephalitis

MalaCards organs/tissues related to Posttransplant Acute Limbic Encephalitis:

40
Skin, Liver, Breast, Kidney, Thyroid, Bone, Eye

Publications for Posttransplant Acute Limbic Encephalitis

Articles related to Posttransplant Acute Limbic Encephalitis:

(show top 50) (show all 8215)
# Title Authors PMID Year
1
Comparison of activity, expression and S-nitrosylation of glycolytic enzymes between pale, soft and exudative and red, firm and non-exudative pork during post-mortem aging. 61
31978718 2020
2
Effects of heat stress on animal physiology, metabolism, and meat quality: A review. 61
31841730 2020
3
Simultaneous measurement of hydrogen carbonate and acetate anions using biologically active receptor based on azo derivatives of naphthalene. 61
31846855 2020
4
A simple fluorophore-imine ensemble for colorimetric and fluorescent detection of CN- and HS- in aqueous solution. 61
31927478 2020
5
A sensitive pH fluorescent probe based on triethylenetetramine bearing double dansyl groups in aqueous solutions and its application in cells. 61
31822453 2020
6
Novel SS18-NEDD4 gene fusion in a primary renal synovial sarcoma. 61
31595587 2020
7
Design and synthesis of malonohydrazide based colorimetric receptors for discrimination of maleate over fumarate and detection of F-, AcO- and AsO2- ions. 61
31818641 2020
8
Shading Effects on Leaf Color Conversion and Biosynthesis of the Major Secondary Metabolites in the Albino Tea Cultivar 'Yujinxiang'. 61
32011878 2020
9
Preliminary Studies on the Application of Grape Seed Extract in the Dyeing and Functional Modification of Cotton Fabric. 61
32024305 2020
10
Hexaarylbutadiene: a versatile scaffold with tunable redox properties towards organic near-infrared electrochromic material. 61
32030909 2020
11
Phenothiazine-rhodamine-based colorimetric and fluorogenic 'turn-on' sensor for Zn2+ and bioimaging studies in live cells. 61
31489767 2020
12
WFDC2 gene deletion in mouse led to severe dyspnea and type-I alveolar cell apoptosis. 61
31780266 2020
13
Novel pararosaniline based optical sensor for the determination of sulfite in food extracts. 61
31627056 2020
14
A highly sensitive and selective Schiff-base probe as a colorimetric sensor for Co2+ and a fluorimetric sensor for F- and its utility in bio-imaging, molecular logic gate and real sample analysis. 61
31606669 2020
15
Procyanidins in rice cooked with adzuki bean and their contribution to the reduction of nitrite to nitric oxide (•NO) in artificial gastric juice. 61
31055987 2020
16
Pulmonary amniotic fluid embolism in a rhesus macaque (Macaca mulatta). 61
31742695 2020
17
An NRAS mutation in primary malignant melanoma of the lung: a case report. 61
32028967 2020
18
Biopsy histopathology in the diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). 61
31705326 2020
19
Determination of optimal sample preparation for aldehyde extraction from pale malts and their quantification via headspace solid-phase microextraction followed by gas chromatography and mass spectrometry. 61
31767258 2020
20
Morphometry and comparative histology of sinus and atrioventricular nodes in humans and pigs and their relevance in the prevention of nodal arrhythmias. 61
31869593 2020
21
Onychomatricoma Micropapilliferum, a New Variant of Onychomatricoma: Clinical, Dermoscopical, and Histological Correlations (Report of 4 Cases). 61
31436573 2020
22
Gene functions in adult cuticle pigmentation of the yellow mealworm, Tenebrio molitor. 61
31812474 2020
23
Pseudolysobacter antarcticus gen. nov., sp. nov., isolated from soil in Fildes Peninsula, Antarctica. 61
32017675 2020
24
Multigene phylogeny and taxonomy of Dendryphion hydei and Torula hydei spp. nov. from herbaceous litter in northern Thailand. 61
32023268 2020
25
Contribution of amylose-procyanidin complexes to slower starch digestion of red-colored rice prepared by cooking with adzuki bean. 61
31986936 2020
26
Immunofluorescent Detection of NET Components in Paraffin-Embedded Tissue. 61
31729002 2020
27
Hydrazone Based Dual - Responsive Colorimetric and Ratiometric Chemosensor for the Detection of Cu2+/F- Ions: DNA Tracking, Practical Performance in Environmental Samples and Tooth Paste. 61
31997143 2020
28
Polyoxometalate-viologen photochromic hybrids for rapid solar ultraviolet light detection, photoluminescence-based UV probing and inkless and erasable printing. 61
31815259 2020
29
A novel method to detect bovine sex pheromones using l-tyrosine-capped silver nanoparticles: Special reference to nanosensor based estrus detection. 61
31884348 2020
30
Zinc(II)-Organic Framework Films with Thermochromic and Solvatochromic Applications. 61
31944445 2020
31
Retained intra-abdominal surgical sponge causing ileocolic fistula diagnosed by colonoscopy. 61
32007866 2020
32
Atlantic Salmon (Salmo salar L., 1758) Gut Microbiota Profile Correlates with Flesh Pigmentation: Cause or Effect? 61
31942646 2020
33
5-ALA fluorescence in a WHO grade I papillary glioneuronal tumour: a case report. 61
31989247 2020
34
Galanin Signaling in the Brain Regulates Color Pattern Formation in Zebrafish. 61
31902721 2020
35
Heterologous expression of xanthophyll esterase genes affects carotenoid accumulation in petunia corollas. 61
31992834 2020
36
Mechanism of Copigmentation of Monoglucosylrutin with Caffeine. 61
31880932 2020
37
Bovine cardiac mesothelial hyperplasia: a common incidental finding in adult cattle. 61
31833454 2020
38
On-site and low-cost detection of cyanide by simple colorimetric and fluorogenic sensors: Smartphone and test strip applications. 61
31594612 2020
39
Synthesis of Silver Nanoparticles Using a Novel Cyanobacteria Desertifilum sp. extract: Their Antibacterial and Cytotoxicity Effects. 61
32021164 2020
40
Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type. 61
31932920 2020
41
Disseminated Mycobacterium kansasii infection in a white-tailed deer and implications for public and livestock health. 61
31845615 2020
42
Recurrent RET Gene Fusions in Pediatric Spindle Mesenchymal Neoplasms. 61
31994201 2020
43
Compound Clear Cell Sarcoma of the Skin-A Potential Diagnostic Pitfall: Report of a Series of 4 New Cases and a Review of the Literature. 61
31688004 2020
44
Pediatric cellular neurothekeoma: Seven cases and systematic review of the literature. 61
31930561 2020
45
Perineurioma -a rare cause of proptosis. 61
31910678 2020
46
A Case of Dendritic Cell Neurofibroma With Pseudorosettes. 61
32000216 2020
47
White Eggshells: A Potential Biowaste Material for Synergetic Adsorption and Naked-Eye Colorimetric Detection of Heavy Metal Ions from Aqueous Solution. 61
31834771 2020
48
Schizostachyum dakrongense (Poaceae, Bambusoideae), a new species from Dakrong Nature Reserve, Vietnam. 61
31988612 2020
49
Clinical Implications of Goblet Cells in Dacryoadenosis and Normal Human Lacrimal Glands. 61
32006483 2020
50
Pale green mutant analyses reveal the importance of CsGLKs in chloroplast developmental regulation and their effects on flavonoid biosynthesis in tea plant. 61
31794899 2020

Variations for Posttransplant Acute Limbic Encephalitis

Expression for Posttransplant Acute Limbic Encephalitis

Search GEO for disease gene expression data for Posttransplant Acute Limbic Encephalitis.

Pathways for Posttransplant Acute Limbic Encephalitis

GO Terms for Posttransplant Acute Limbic Encephalitis

Sources for Posttransplant Acute Limbic Encephalitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....